93 related articles for article (PubMed ID: 38726038)
1. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
Feder A; Costi S; Rutter SB; Collins AB; Govindarajulu U; Jha MK; Horn SR; Kautz M; Corniquel M; Collins KA; Bevilacqua L; Glasgow AM; Brallier J; Pietrzak RH; Murrough JW; Charney DS
Focus (Am Psychiatr Publ); 2023 Jul; 21(3):296-305. PubMed ID: 37404970
[TBL] [Abstract][Full Text] [Related]
2. Exploring Predictors of Ketamine Response in Adolescent Treatment-Resistant Depression.
Lineham A; Avila-Quintero VJ; Bloch MH; Dwyer J
J Child Adolesc Psychopharmacol; 2024 Mar; 34(2):73-79. PubMed ID: 38170185
[No Abstract] [Full Text] [Related]
3. Case series of intravenous ketamine infusion in patients with suicidal thought.
Sharma P; Dubey A; Gajbhiye D; Sharma A; Kant A
Ind Psychiatry J; 2023; 32(2):437-440. PubMed ID: 38161461
[TBL] [Abstract][Full Text] [Related]
4. Ketamine reduces the neural distinction between self- and other-produced affective touch: a randomized double-blind placebo-controlled study.
Kaldewaij R; Salamone PC; Enmalm A; Östman L; Pietrzak M; Karlsson H; Löfberg A; Gauffin E; Samuelsson M; Gustavson S; Capusan AJ; Olausson H; Heilig M; Boehme R
Neuropsychopharmacology; 2024 Jun; ():. PubMed ID: 38918578
[TBL] [Abstract][Full Text] [Related]
5. Ketamine in Substance Use Disorder Treatment: A Narrative Review.
Famuła A; Radoszewski J; Czerwiec T; Sobiś J; Więckiewicz G
Alpha Psychiatry; 2024 Mar; 25(2):206-211. PubMed ID: 38798813
[TBL] [Abstract][Full Text] [Related]
6. Seeing awe: How children perceive awe-inspiring visual experiences.
O'bi A; Yang F
Child Dev; 2024; 95(4):1271-1286. PubMed ID: 38294048
[TBL] [Abstract][Full Text] [Related]
7. Wonder and awe: Developmental biology inspires.
Cell Editorial team
Cell; 2024 Jun; 187(13):3163-3164. PubMed ID: 38906092
[TBL] [Abstract][Full Text] [Related]
8. Virtual Awe: Expanding the Horizons of Mental Health Treatment.
Wiederhold BK
Cyberpsychol Behav Soc Netw; 2024 Jun; ():. PubMed ID: 38916069
[No Abstract] [Full Text] [Related]
9. Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder.
Dean RL; Marquardt T; Hurducas C; Spyridi S; Barnes A; Smith R; Cowen PJ; McShane R; Hawton K; Malhi GS; Geddes J; Cipriani A
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD011611. PubMed ID: 34623633
[TBL] [Abstract][Full Text] [Related]
10. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
[TBL] [Abstract][Full Text] [Related]
11. Experiences of Awe Mediate Ketamine's Antidepressant Effects: Findings From a Randomized Controlled Trial in Treatment-Resistant Depression.
Aepfelbacher J; Panny B; Price RB
Biol Psychiatry Glob Open Sci; 2024 Jul; 4(4):100316. PubMed ID: 38726038
[TBL] [Abstract][Full Text] [Related]
12. The Relationship Between Acute Dissociative Effects Induced by Ketamine and Treatment Response in Adolescent Patients with Treatment-Resistant Depression.
Lineham A; Avila-Quintero VJ; Bloch MH; Dwyer J
J Child Adolesc Psychopharmacol; 2023 Feb; 33(1):20-26. PubMed ID: 36799961
[No Abstract] [Full Text] [Related]
13. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.
Zarate CA; Brutsche NE; Ibrahim L; Franco-Chaves J; Diazgranados N; Cravchik A; Selter J; Marquardt CA; Liberty V; Luckenbaugh DA
Biol Psychiatry; 2012 Jun; 71(11):939-46. PubMed ID: 22297150
[TBL] [Abstract][Full Text] [Related]
14. Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine and esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial.
Echegaray MVF; Mello RP; Magnavita GM; Leal GC; Correia-Melo FS; Jesus-Nunes AP; Vieira F; Bandeira ID; Caliman-Fontes AT; Telles M; Guerreiro-Costa LNF; Marback RF; Souza-Marques B; Lins-Silva DH; Santos-Lima C; Cardoso TA; Kapczinski F; Lacerda ALT; Quarantini LC
Trends Psychiatry Psychother; 2023 Sep; ():. PubMed ID: 37717263
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
